INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![clinical-drug-development-GettyImages-1354172647]( "Trailblazing Clinical Drug Development In Dermatology")
Trailblazing Clinical Drug Development In DermatologyAI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.
-
![medical analytics, digital AI interface, DNA insights, machine learning, healthcare-GettyImages-2262212754]( "Own Your Data, Accelerate Your Cure")
Own Your Data, Accelerate Your CureMove from passive donor to active innovator. Explore how patient communities are building their own research infrastructure and using AI to bypass traditional barriers to drug development.
-
![Clinical Tech Week]( "Enhance Data Collection And Ensure Seamless Platform Integration")
Enhance Data Collection And Ensure Seamless Platform IntegrationDiscover how to enable patient- and site-centric data collection, enhance participant engagement, reduce burden, and deliver valuable real-world insights on treatment effectiveness and quality of life.
-
![Practical ICH E6]( "Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy")
Practical ICH E6(R3) Oversight For Your Centralized Monitoring StrategyBridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.
-
Navigating Disclosure Complexity: The Power Of Human-Centered AI9/25/2025
Identify key regulatory hurdles that sponsors face when integrating Artificial Intelligence (AI), as well as the impact of AI on clinical trial disclosure and transparency.
-
2025 Big Ideas In Clinical Trials: A Conversation7/30/2025
Clinical trials are being redefined by three key forces: true patient-centricity, a rising focus on corporate responsibility and sustainability, and the push for greater efficiency through innovative designs.
-
The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More3/25/2026
High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.
-
Agentic AI Is Transforming Life Sciences Discovery And Operations1/8/2026
73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
Paper COAs In 2026? It's Not "Cheaper," It's Riskier4/1/2026
Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![Castor Catalyst]( "Benefit For An AI-Automated Extraction Model")
Modernize your research by replacing manual data entry with automated extraction. Ensure regulatory-grade evidence and full data traceability for faster, more reliable results.
-
![Quality control assurance satisfaction-GettyImages-2117357383]( "Ergomed's Risk-Based Quality Management")
Ergomed’s Meticulous Risk-Based Quality Management Approach
As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Trial Enablement Solutions")
Digital health technologies have the potential to transform clinical trials, yet without careful planning and support, their implementation can increase site burden and jeopardize data quality.
-
![GettyImages-2081140990-phone-cellphone-hand]( "Make Participating In Your Clinical Trial Easier Than Ever")
The success of clinical trials depends on patient participation.
But patients and caregivers need reliable support first.
Being part of a trial is often nuanced and time-consuming. Archaic travel, antiquated payment processes and card fees are not only frustrating, but can also chip away at the reimbursement funds participants are owed.
This isn’t what you want for your participants, but you haven’t had a better choice. If we have the technology to make things better, we should. So we are.
Mural Link is the clinical research industry’s first participant management platform, designed to meet the needs of modern-day participants, help them enroll and remain in a trial, and reduce the administrative burden for sites.
-
![GettyImages-1295294256 doctor phone data]( "Fast. Flexible. Proven. IQVIA eCOA.")
A responsive solution, see how IQVIA's electronic clinical outcome assessments are leveraging technology to gather valuable insights about the patient and caregiver experience.
